INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 411m ago
HOUSE PTR11m ago
SEC 13F10m ago
ROBINHOOD CHAIN10m ago
SEC FORM 4/Open-market saleVerified data

Bradley Mark Christopher sold ALMS

Chief Development Officer · ALUMIS INC. · Common Stock

Side
SELL
Value
$4,062
Shares
623
Price
$6.52
Executed
Nov 2, 2026
Disclosed
Nov 4, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 2 executedNov 4, 2026 disclosed

ALMS · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
36/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $4K reported value · 1.3% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+15 / 15

    5 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ALMS

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    36
    PS
    Pangali SanamChief Legal Officer
    ALMSALUMIS INC.
    Open-market sale
    		SELL$2,165
    332 sh
    		Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    		+2dSEC FORM 4

    Evidence

    36
    DJ
    Drappa JornChief Medical Officer
    ALMSALUMIS INC.
    Open-market sale
    		SELL$3,866
    593 sh
    		Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    		+2dSEC FORM 4

    Evidence

    36
    GM
    Goldstein David MChief Scientific Officer
    ALMSALUMIS INC.
    Open-market sale
    		SELL$4,101
    629 sh
    		Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    		+2dSEC FORM 4

    Evidence

    36
    SR
    Schroer John R.Chief Financial Officer
    ALMSALUMIS INC.
    Open-market sale
    		SELL$5,177
    794 sh
    		Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    		+2dSEC FORM 4

    Evidence

    36
    HC
    Hardiman Roy C.Chief Business & Strategy Ofcr
    ALMSALUMIS INC.
    Open-market sale
    		SELL$4,251
    652 sh
    		Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SR
    Schroer John R.Chief Financial Officer
    ALMSALUMIS INC.
    Grant or award
    		A—
    202.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    PS
    Pangali SanamChief Legal Officer
    ALMSALUMIS INC.
    Grant or award
    		A—
    186.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BC
    Bradley Mark ChristopherChief Development Officer
    ALMSALUMIS INC.
    Grant or award
    		A—
    190.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    DJ
    Drappa JornChief Medical Officer
    ALMSALUMIS INC.
    Grant or award
    		A—
    221.4K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    GM
    Goldstein David MChief Scientific Officer
    ALMSALUMIS INC.
    Grant or award
    		A—
    216.7K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002023657-26-000007
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 2, 2026
    Published
    Nov 4, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 5, 13:39 UTC

    Extracted facts

    Filer
    Bradley Mark Christopher
    Role
    Chief Development Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    ALUMIS INC.
    Ticker
    ALMS
    Shares
    623
    Price per share
    $6.52
    Value
    $4,062
    Execution date (reported)
    Nov 2, 2026
    Owned after transaction
    47.9K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 623
    • Price: $6.52

    = $4,062

    What this establishes

    Bradley Mark Christopher filed this Form 4 reporting a open-market sale of ALMS on Nov 2, 2026. It became public on Nov 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Development Officer
    Bradley Mark Christophercik:0002023657
    Issuer
    ALUMIS INC.cik:0001847367

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.